No consensus regarding optimal treatment or etiology of Preiser disease exists. We described the epidemiology, classification and treatment characteristics of 18 patients with Preiser disease. Patients with changes related to previous trauma, and without radiographs were excluded. Based on the radiographs at diagnosis, we classified 13 scaphoids as Herbert Lanzetta stage II, four as stage III, and one as stage IV. In 12 patients nonspecific treatment was offered and only two patients received surgical treatment. We found that chosen treatment is not associated with the severity of Herbert Lanzetta stage and the outcome is not influenced by chosen treatment. Level of evidence: I
Claessen, F., Schol, I., Kolovich, G., Ring, D. (2020). Avascular Necrosis of the Scaphoid Preiser Disease. The Archives of Bone and Joint Surgery, 8(1), 94-98. doi: 10.22038/abjs.2019.39187.2047
MLA
Femke M.A.P. Claessen; Ilse Schol; Gregory P. Kolovich; David Ring. "Avascular Necrosis of the Scaphoid Preiser Disease". The Archives of Bone and Joint Surgery, 8, 1, 2020, 94-98. doi: 10.22038/abjs.2019.39187.2047
HARVARD
Claessen, F., Schol, I., Kolovich, G., Ring, D. (2020). 'Avascular Necrosis of the Scaphoid Preiser Disease', The Archives of Bone and Joint Surgery, 8(1), pp. 94-98. doi: 10.22038/abjs.2019.39187.2047
VANCOUVER
Claessen, F., Schol, I., Kolovich, G., Ring, D. Avascular Necrosis of the Scaphoid Preiser Disease. The Archives of Bone and Joint Surgery, 2020; 8(1): 94-98. doi: 10.22038/abjs.2019.39187.2047
)